Rigel Pharmaceuticals, Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:RIGL) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -893 K30.54 M24.03 M21.98 M2.73 M 79.27 M Cash from investing activities -10.55 M-23.28 M-33.17 M-25.36 M-7.97 M -89.79 M Cash from financing activities 484 K418 K4.27 M-4.57 M-10.92 M -10.8 M Free cash flow -893 K30.54 M24.03 M21.98 M2.73 M 79.27 M

News

Bioventus (BVS) Soars 12.4%: Is Further Upside Left in the Stock?

A Look At The Transformation Around Rigel Pharmaceuticals (NASDAQ:RIGL)

Rigel Pharmaceuticals, Inc. (RIGL) M&A Call - Slideshow (NASDAQ:RIGL) 2026-05-20

Rigel Pharmaceuticals, Inc. (RIGL) M&A Call Transcript

Arvinas: FDA Approval Validates The Platform, But Does Not Signal Near-Term Profitability

Rigel Pharmaceuticals (RIGL) Lags Q1 Earnings and Revenue Estimates

Rigel Pharmaceuticals, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:RIGL) 2026-05-05

Guardian Pharmacy Services (GRDN) Reports Next Week: Wall Street Expects Earnings Growth

Rigel Pharmaceuticals (RIGL) to Report Q1 Results: Wall Street Expects Earnings Growth

Is the Options Market Predicting a Spike in Rigel Pharmaceuticals Stock?

Rigel Pharmaceuticals Was Easy To Dismiss - Now It's Hard To Ignore (NASDAQ:RIGL)

Madrigal (MDGL) Surges 12.3%: Is This an Indication of Further Gains?